Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures.
Life sciences software solutions provider Labviva has announced a strategic supply partnership with Gilson that will see the laboratory instruments manufacturer’s liquid handling, purification and extraction systems become readily available to organisations, including large pharmaceuticals, research institutions, and biotechnology firms, directly from Labviva’s procurement platform. Click to read more.